DaHee Han

PharmD

Most Recent Articles by DaHee Han

Benralizumab Efficacy Maintained in Long-Term Severe Eosinophilic Asthma Study

Benralizumab Efficacy Maintained in Long-Term Severe Eosinophilic Asthma Study

By

Results from the extension trial showed a similar safety and tolerability profile for Fasenra as that seen in SIROCCO and CALIMA.

Ofev Shown to Slow Idiopathic Pulmonary Fibrosis Progression Long-Term

Ofev Shown to Slow Idiopathic Pulmonary Fibrosis Progression Long-Term

By

The primary objective was to characterize the long-term safety and tolerability of Ofev in patients with IPF; efficacy endpoints included annual rate of decline in forced vital capacity (FVC) calculated over 192 weeks.

Tezepelumab Gets Breakthrough Therapy Designation for Severe Asthma

Tezepelumab Gets Breakthrough Therapy Designation for Severe Asthma

By

The designation was based on data from the Phase 2b PATHWAY trial that evaluated 3 doses of tezepelumab as add-on therapy in patients with a history of asthma exacerbations and uncontrolled asthma receiving inhaled corticosteroids/long-acting β-agonist with or without oral corticosteroids and additional asthma controllers vs placebo.

RET Inhibitor Gets Breakthrough Tx Status for NSCLC, Medullary Thyroid Cancer

RET Inhibitor Gets Breakthrough Tx Status for NSCLC, Medullary Thyroid Cancer

By

LOXO-292 is being evaluated in the ongoing Phase 1/2 LIBRETTO-001 clinical trial.

Veta Smart Case, App for Epinephrine Auto-Injectors Now Available

Veta Smart Case, App for Epinephrine Auto-Injectors Now Available

By

The Smart Case includes electronics and sensors to monitor the proximity, temperature, presence and removal, and expiration of auto-injectors.

More Articles by DaHee Han

Sign Up for Free e-newsletters